CORRECTING and REPLACING Andersen Global Caps Another Year of Strong Growth with the Addition of 11 New Member Firms Worldwide
31.1.2023 23:19:00 EET | Business Wire | Press release
Tenth bullet point in release should read: MGC Legal (Turkey) (instead of MCG Legal (Turkey)).
Additionally, remove Bangladesh from the list of countries in the Africa section.
The updated release reads:
ANDERSEN GLOBAL CAPS ANOTHER YEAR OF STRONG GROWTH WITH THE ADDITION OF 11 NEW MEMBER FIRMS WORLDWIDE
Growing Global Footprint Provides Multinational Clients with Independent, Best-In-Class, Multidisciplinary Services
Andersen Global, the worldwide leader in tax and legal services, welcomes 11 member firms to its platform, increasing its ability to provide independent, multidisciplinary, borderless service to its global clients. Through its member and collaborating firms, Andersen Global has over 13,000 professionals and a presence in over 390 locations in more than 170 countries on six continents, giving it one of the largest global footprints among multinational, multidisciplinary professional services firms.
New member firms of the organization include:
- A&A Tax (Australia)
- Law Firm SAJIĆ (Bosnia and Herzegovina)
- CN Law (Burundi)
- Nimba Conseil (Guinea)
- Saint Lawrence Tax Consultancy (Jordan)
- Unicase (Kazakhstan)
- Halim Hong & Quek (Malaysia)
- Tax & Legal Advisers LLC (Tajikistan)
- ECC Denetim (Turkey)
- MGC Legal (Turkey)
- Intuit Management Consultancy (United Arab Emirates, Singapore, India)
“As a firm, we’ve taken tremendous strides in the last year to deepen our capabilities across key markets and specialties, including mergers and acquisitions, valuation and global mobility, to become a true one-stop-shop for our multinational clients,” said Andersen Global Chairman and Andersen CEO Mark Vorsatz. “These member firms reinforce our global approach, further unify the Andersen brand, and enable us to deliver seamless global service, positioning us well for continued growth.”
Andersen Global has grown rapidly since its establishment in 2013. Over the past five years alone, the global organization has expanded into more than 150 countries, averaging more than a deal per week during that time. In 2022 alone, Andersen Global added a new presence or expanded its current footprint in more than 50 new locations and increased its ranks by over 2,000 professionals.
Countries in which Andersen announced an expanded presence in 2022 include:
Africa
Central African Republic, Chad, Ethiopia, Ghana, Mali, Rwanda, and Tanzania
Americas and the Caribbean
Brazil, the British Virgin Islands, Canada, Guadalupe, Montserrat
Asia and Asia Pacific
Australia, Bangladesh, Indonesia, New Zealand, South Korea, Sri Lanka, Taiwan, and Thailand
Europe
Austria, Belgium, Denmark, Estonia, Finland, France, Iceland, Latvia, Lithuania, Slovakia, Slovenia, Switzerland, and the United Kingdom
Middle East
Pakistan
Andersen Global is an international association of legally separate, independent member firms comprised of tax and legal professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 13,000 professionals worldwide and a presence in over 390 locations through its member firms and collaborating firms.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005355/en/
Contact information
Megan Tsuei
Andersen Global
415-764-2700
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom